belladonna-opium
Belladonna-opium (B&O) suppositories are commercially available again after discontinuation. In December 2024, P&T approved re-addition to formulary, and implementation is pending.
Belladonna-opium (B&O) suppositories are commercially available again after discontinuation. In December 2024, P&T approved re-addition to formulary, and implementation is pending.